Stop weight-loss drugs and weight returns. Support slowed it here.
People say: “When you stop the drug, the weight just comes back” We read the study.
Randomised controlled trial (RCT). 39 people. 4 months after stopping GLP-1 medication (study ran 3/2024-8/2025).
A trial. Chance decided who did what.
Who: US adults (Dallas and El Paso obesity clinics + StudyFinder) who had lost >10% of body weight on a GLP-1 drug and had stopped it less than 30 days before; mean age 49.9, 82.1% women, mean BMI 31.4, mean weight lost on the drug 18.1%; drugs: semaglutide 48.7%, cagrilintide+semaglutide 35.9%, tirzepatide 10.3%
- Usual care+10.8%weight regained
- Diet coaching app+3.6%weight regained
- Healthy ready meals+3.6%weight regained
More to know, from our read of the paper:
- Small pilot: 39 randomized (14/12/13), 34 completed a final weigh-in; target of 60 not reached; not powered for definitive efficacy (authors). Results need larger, longer trials
- Short: 4 months only; says nothing about long-term regain
- Weight was not the primary outcome (adherence and satisfaction were, and showed no clear differences); weight was a pre-registered secondary outcome, called 'exploratory' in the abstract
- Groups were unbalanced at baseline: the control group was 100% women, lighter (76.5 kg vs 91.4/87.9) and had lost more on the drug (21.2% vs 17.7%/15.6%). Adjusting for weight lost on GLP-1 and baseline weight shrank the differences a little but they stayed significant (app -5.83 pts, meals -6.29 pts, Table S1 per text)
- Usual care was not standardised (left to each provider). Interventions were free to participants (study-paid); real-world cost ~$372/month for meals, ~$17-70/month for apps (Introduction)
Early support slowed regain. Small trial, not settled.
- Plan support for the stopMeals or an app slowed regain here.
This small pilot trial randomized 39 US adults who had just stopped a GLP-1 drug (after losing about 18% of their weight on it) to usual care, a diet coaching app or 10 healthy ready-made meals a week, for 4 months. Usual care regained about 10.8% of body weight; the app and meals groups regained about 3.6%. Weight was measured on home smart scales. It is small, short and the groups started a bit different, so larger, longer trials are needed.
Hollis-Hansen K, Vonderschmidt A, Haskins C, Kane RM, Almandoz JP, Lingvay I (2026). Preventing Weight Regain After Glucagon-Like Peptide-1 Therapy Discontinuation: A Pilot Randomized Controlled Trial. Obesity Science & Practice.
Design: Randomised controlled trial (RCT) · pilot randomized controlled trial, fully remote, 3 arms (usual care vs a digital wellness app [Noom] vs medically tailored meals), pre-registered (NCT06273163); weight was a pre-registered secondary outcome (called exploratory in the abstract), primary outcomes were adherence and satisfaction; outcome assessor masked, participants not
DOI: 10.1002/osp4.70194
Goals:
We read the abstract and the full text of this paper and checked every number on this page against it (16 facts, checked on 2026-10-29). The study design is named above. Cohort and other observational studies are described as linked, not proven. Found an error? Email theis@onestudyaday.com.
Join the waitlist: one checked study a day for your goal, by email
Pick up to three goals. We email you once when the daily study starts. The goals for this study are ticked already.